- Home
- COYA vs ZTEK Comparison
COYA vs ZTEK Comparison
Compare COYA & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COYA
- ZTEK
- Stock Information
- Founded
- COYA 2020
- ZTEK 2008
- Country
- COYA United States
- ZTEK Canada
- Employees
- COYA N/A
- ZTEK N/A
- Industry
- COYA Biotechnology: Pharmaceutical Preparations
- ZTEK Major Chemicals
- Sector
- COYA Health Care
- ZTEK Industrials
- Exchange
- COYA Nasdaq
- ZTEK Nasdaq
- Market Cap
- COYA 107.0M
- ZTEK 91.6M
- IPO Year
- COYA 2022
- ZTEK N/A
- Fundamental
- Price
- COYA $5.61
- ZTEK $0.96
- Analyst Decision
- COYA Strong Buy
- ZTEK
- Analyst Count
- COYA 4
- ZTEK 0
- Target Price
- COYA $16.50
- ZTEK N/A
- AVG Volume (30 Days)
- COYA 116.6K
- ZTEK 835.2K
- Earning Date
- COYA 11-05-2025
- ZTEK 11-13-2025
- Dividend Yield
- COYA N/A
- ZTEK N/A
- EPS Growth
- COYA N/A
- ZTEK N/A
- EPS
- COYA N/A
- ZTEK N/A
- Revenue
- COYA $423,452.00
- ZTEK $678,078.00
- Revenue This Year
- COYA $40.80
- ZTEK N/A
- Revenue Next Year
- COYA N/A
- ZTEK N/A
- P/E Ratio
- COYA N/A
- ZTEK N/A
- Revenue Growth
- COYA N/A
- ZTEK 2519.47
- 52 Week Low
- COYA $4.65
- ZTEK $0.50
- 52 Week High
- COYA $10.24
- ZTEK $1.84
- Technical
- Relative Strength Index (RSI)
- COYA 38.75
- ZTEK 59.14
- Support Level
- COYA $5.37
- ZTEK $0.65
- Resistance Level
- COYA $6.53
- ZTEK $1.07
- Average True Range (ATR)
- COYA 0.43
- ZTEK 0.12
- MACD
- COYA -0.12
- ZTEK 0.02
- Stochastic Oscillator
- COYA 15.89
- ZTEK 55.59
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.